Top

The Patient - Patient-Centered Outcomes Research

Published in:

01-03-2014 | Original Research Article

Evaluation of Patient Satisfaction with Diabetes Management Provided by Clinical Pharmacists in the Patient-Centered Medical Home

Authors: M. Shawn McFarland, Juliet P. Wallace, Jessica Parra, Jennifer Baker

Published in: The Patient - Patient-Centered Outcomes Research | Issue 1/2014

Abstract

Study Objective

The patient-centered medical home (PCMH) model is a multidisciplinary, team-based approach to healthcare that focuses on actively involving the patient in clinical decision making. Multiple studies have demonstrated improved clinical outcomes from utilizing clinical pharmacists in the primary care setting, particularly in management of diabetes. No study has evaluated patient satisfaction with pharmacist in the PCMH model. Our objective was to evaluate patient satisfaction of care received in pharmacist-managed primary care clinics among patients with diabetes mellitus within the PCMH.

Design

This study was a single-center, cross-sectional analysis of patients who were seen by a clinical pharmacy specialist (CPS).

Setting

The setting for this study was eight outpatient primary care clinics within a Veterans Affairs healthcare system where diabetes management services were provided by eight CPSs.

Patients

A total of 1,468 patients with a hemoglobin A_1c >7.0 % who were seen in clinic by a CPS at the primary care clinics between 1 October 2008 and 1 April 2012 were mailed the Modified Diabetes Disease State Management Questionnaire (DDSM-QM). The DDSM-QM was a 15-item questionnaire that assessed overall patient satisfaction with pharmacist care, as well as patient satisfaction within three major domains: ‘service,’ ‘self-management,’ and ‘knowledge’.

Measurements and Main Results

A response rate of 42.7 % was attained, with 627 patients consenting to participate by completing and returning the self-administered questionnaire. The mean overall satisfaction score was 90.6 ± 10.6 % (mean ± standard deviation). Mean percentage scores within the ‘service,’ ‘knowledge,’ and ‘self-management’ domains were 92.0 ± 10.8, 89.7 ± 11.3, and 89.2 ± 12.0 %, respectively.

Conclusion

Patients with diabetes seen by a CPS within the PCMH model were very satisfied with the care they received overall.

Carrier E, Gourevitch MN, Shah NR. Medical homes: challenges in translating theory into practice. Med Care. 2009;49(7):714–22.CrossRef

Sia C, Tonniges TF, Osterhus E, Taba S. History of the medical home concept. Pediatrics. 2004;113:1473–8.PubMed

American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College of Physicians (ACP), American Osteopathic Association (AOA). Joint principles of the patient-centered medical home. February 2007 (cited 4 Sept 2009). Available from: http://www.aafp.org/online/etc/medialib/aafp_org/documents/policy/fed/jointprinciplespcmh0207.Par.0001.File.tmp/022107medicalhome.pdf.

VHA PCMH Model Concept Paper. Patient Centered Primary Care Implementation Work Group. 2010. http://www.va.gov/PrimaryCare/docs/pcmh_ConceptPaper.doc. Accessed 15 Oct 2013.

Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.PubMedCrossRef

Edwards HD, Webb RD, Scheid DC, Britton ML, Armor BL. A pharmacist visit improves diabetes standards in a patient-centered medical home. Am J Med Qual. 2012 Jun 7. (Epub ahead of print).

Ladhani NN, Majumbar SR, Johnson JA, Tsuyuki RT, Lewanczuk RZ, Spooner R, et al. Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in Type 2 diabetic patients without established cardiovascular disease: results from a randomized trial. Diabet Med. 2012. doi:10.1111/j.1464-5491.2012.03673.x. (Epub ahead of print).

Wallgren S, Berry-Caban CS, Bowers L. Impact of clinical pharmacist intervention on diabetes-related outcomes in a military treatment facility. Ann Pharmacother. 2012;46(3):353–7.PubMedCrossRef

Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther. 2012;17(1):57–64.PubMedCrossRef

10.

Warrington L, Ayers P, Baldwin AM, Wallace V, Ricke KD, Saulters R, et al. Implementation of a pharmacist-led, multidisciplinary diabetes management team. Am J Health Syst Pharm. 2012;69(14):1240–5.PubMedCrossRef

11.

Pepper MJ, Mallory N, Coker TN, Chaki A, Sando KR. Pharmacists’ impact on improving outcomes in patients with type 2 diabetes mellitus. Diabetes Educ. 2012;38(3):409–16.PubMedCrossRef

12.

Cripps RJ, Johnson W, Cassidy R, Morgan T, Venugopal D, McFarland MS. An evaluation of diabetes-related measures of control after 6 months of clinical pharmacy specialist intervention. J Pharm Pract. 2011;24(3):332–8.PubMedCrossRef

13.

McFarland M, Davis K, Wallace J, Wan J, Cassidy R, Morgan T, Venugopal D. Use of home telehealth monitoring with active medication therapy management by clinical pharmacists in veterans with poorly controlled type 2 diabetes mellitus. Pharmacother. 2012;32(5):420–6.CrossRef

14.

Marquis M, Davies A, Ware J. Patient satisfaction and change in medical care provider: a longitudinal study. Med Care. 1983;21:821–9.PubMedCrossRef

15.

Bartlett E, Grayson M, Barker R. The effect of physician communication skills on patient satisfaction, recall, and adherence. J Chronic Dis. 1984;37:744–64.CrossRef

16.

Collins C, Kramer A, O’Day ME, Low MB. Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health-Syst Pharm. 2006;63:1723–7.PubMedCrossRef

17.

Moczygemba LR, Barner JC, Brown CM, Lawson KA, Gabrillo ER, Godley P, et al. Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Res Soc Adm Pharm. 2010;6:143–54.CrossRef

18.

Panvelkar PN, Saini B, Armour C. Measurement of patient satisfaction with community pharmacy services: a review. Pharm World Sci. 2009;31:525–37.CrossRef

19.

Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P, et al. Patient evaluation of a community pharmacy medications management service. Ann Pharmacother. 2007;41:1962–70.PubMedCrossRef

20.

Krass I, Delaney C, Glaubitz, Kanjanarach T. Measuring patient satisfaction with diabetes disease state management services in community pharmacy. Res Soc Adm Pharm. 2009;5:31–39.

21.

Holsclaw SL, Olson KL, Hornak R, et al. Assessment of patient satisfaction with telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service. J Manag Care Pharm. 2005;11:403–9.PubMed

22.

Patient Centered Primary Care Collaborative. http://www.pcpcc.net/. Accessed 7 March 2013.

23.

Patient-Centered Primary Care Collaborative. The patient-centered medical home: Integrating comprehensive medication management to optimize patient outcomes. June 2012. Available at http://www.pcpcc.org/guide/patient-health-through-medication-management. Accessed 29 March 2013.

Title: Evaluation of Patient Satisfaction with Diabetes Management Provided by Clinical Pharmacists in the Patient-Centered Medical Home
Authors: M. Shawn McFarland
Juliet P. Wallace
Jessica Parra
Jennifer Baker
Publication date: 01-03-2014
Publisher: Springer International Publishing
Published in: The Patient - Patient-Centered Outcomes Research / Issue 1/2014
Print ISSN: 1178-1653
Electronic ISSN: 1178-1661
DOI: https://doi.org/10.1007/s40271-013-0039-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Study Objective

Design

Setting

Patients

Measurements and Main Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

Segmenting Patients and Physicians Using Preferences from Discrete Choice Experiments

Painful Diabetic Peripheral Neuropathy: Results of a Survey Characterizing the Perspectives and Misperceptions of Patients and Healthcare Practitioners

Aligning Research and Practice: Implications of Patient-Centered Care for Placebo Effects

Quality of Life in Organ Transplant Recipients Participating in an Online Transplant Community

Validity and Reliability of the Assessment of Quality of Life (AQoL)-8D Multi-Attribute Utility Instrument

Hostile Sexist Male Patients and Female Doctors: A Challenging Encounter

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials